BTK Inhibitors in CLL/SLL and MCL
Key Considerations for the Individualizing Use of BTK Inhibitors in B-Cell Malignancies

Released: October 11, 2023

Matthew S Davids
Matthew S Davids, MD, MMSc
Josie Montegaard
Josie Montegaard, MSN, AGPCNP-BC

Activity

Progress
1
Course Completed